ECSP971998A - CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING - Google Patents

CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING

Info

Publication number
ECSP971998A
ECSP971998A ECSP971998A ECSP971998A EC SP971998 A ECSP971998 A EC SP971998A EC SP971998 A ECSP971998 A EC SP971998A EC SP971998 A ECSP971998 A EC SP971998A
Authority
EC
Ecuador
Prior art keywords
sugar coating
steroids
controlled release
hormonal steroid
active agents
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Barcomb Joseph Reginald
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP971998 priority Critical patent/ECSP971998A/en
Publication of ECSP971998A publication Critical patent/ECSP971998A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

En una tableta farmacéutica que comprende una sustancia interna y un recubrimiento de azúcar, en el cual dicha sustancia contiene agentes no farmacéuticamente activos o uno o más agentes no esteroidales, farmacéuticamente activos que son convencionalmente administrados en conjunto con un esteroide hormonal, el mejoramiento que comprende la incorporación de un esteroide hormonal y un esteroide hormonal desprende el promediode control de la cantidad de celulosa micocristalina en dicho recubrimiento azúcar.In a pharmaceutical tablet comprising an internal substance and a sugar coating, wherein said substance contains non-pharmaceutically active agents or one or more non-steroidal, pharmaceutically active agents that are conventionally administered in conjunction with a hormonal steroid, the improvement comprising the incorporation of a hormonal steroid and a hormonal steroid gives off the average control of the amount of mycrystalline cellulose in said sugar coating.

ECSP971998 1997-01-15 1997-01-15 CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING ECSP971998A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP971998 ECSP971998A (en) 1997-01-15 1997-01-15 CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP971998 ECSP971998A (en) 1997-01-15 1997-01-15 CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING

Publications (1)

Publication Number Publication Date
ECSP971998A true ECSP971998A (en) 1998-04-07

Family

ID=42042832

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP971998 ECSP971998A (en) 1997-01-15 1997-01-15 CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATING

Country Status (1)

Country Link
EC (1) ECSP971998A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11793812B2 (en) 2016-09-30 2023-10-24 Sumitomo Pharma Switzerland Gmbh Methods of treating endometriosis
US12551447B2 (en) 2020-05-29 2026-02-17 Sumitomo Pharma Co., Ltd. Combination solid oral dosage forms of gonadotropin-releasing hormone antagonists

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11793812B2 (en) 2016-09-30 2023-10-24 Sumitomo Pharma Switzerland Gmbh Methods of treating endometriosis
US11957684B2 (en) 2016-09-30 2024-04-16 Sumitomo Pharma Switzerland Gmbh Treatment of heavy menstrual bleeding associated with uterine fibroids
US12551447B2 (en) 2020-05-29 2026-02-17 Sumitomo Pharma Co., Ltd. Combination solid oral dosage forms of gonadotropin-releasing hormone antagonists

Similar Documents

Publication Publication Date Title
CO4780019A1 (en) CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATINGS
DE69918310D1 (en) TABLET WITH DELAYED RELEASE CONTAINING A BLOOD GLUCOSE-LOWING ACTIVE SUBSTANCE AND AN ANI-HYPERGLYZEMIC ACTIVE SUBSTANCE
ATE251449T1 (en) FLAVOR-MASKED ORAL PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED DELIVERY
AU4989997A (en) Soluble form osmotic dose delivery system
GT199900151A (en) DRUG CONTROLLED DELIVERY SYSTEM ORALALLY ADMINISTERED, PROVIDING TEMPORARY AND SPACE CONTROL.
ES2137627T3 (en) NEW COATING COMPOSITION BASED ON A SUGAR, FOR APPLICATION TO COMPRESSED MEDICINAL TABLETS.
FI930862A0 (en) EN DOSERINGSFORM FOER TIDSVARIERANDE MOENSTER AV LAEKEMEDELOEVERLAOTELSE
ES2153836T3 (en) MASK COMPOSITION OF THE FLAVOR OF AMARGOS PHARMACEUTICAL AGENTS.
WO2000025753A3 (en) Controlled delivery of active agents
ATE476957T1 (en) FONDANT-BASED PHARMACEUTICAL COMPOSITION
UY27532A1 (en) DOSAGE FORM OF DUAL CONTROLLED RELEASE.
MX166703B (en) PHARMACEUTICAL PREPARATION FOR SUSTAINED RELEASE
NO20003159L (en) Double capsule for the administration of active principles in multiple therapies
DE69710757D1 (en) PHARMACEUTICAL FORM CONTAINING MILNACIPRANE WITH DELAYED DELIVERY OF ACTIVE SUBSTANCE
TR199901669T2 (en) Required dosage forms and method for the treatment of erectile dysfunction in men.
BR9811381A (en) Processes for treating a mammalian organism to obtain a desired local or systemic physiological or pharmacological effect, for treating a mammalian organism for cytomegalovirus retinitis, to provide controlled and prolonged administration of an agent effective in obtaining a desired physiological or local or systemic pharmacological, and, prolonged release drug delivery system
WO2001000223A3 (en) Multiple agent diabetes therapy
UY26876A1 (en) HYDROGEL ACTIVATED DRUG DOSAGE FORM
KR980700071A (en) Transdermal System for the Simultaneous Delivery of a Number of Active Principles
DE69811278D1 (en) Gastric juice-protected omeprazole microgranules, manufacturing process and pharmaceutical preparations
ES2139002T3 (en) CYTOTOXIC DRUG THERAPY.
HRP20010684B1 (en) DIRECTLY STLACITIC MATRIX FOR CONTROLLED RELEASE OF A SINGLE-DAILY DOSE OF CLARITROMYCIN
CA2348474A1 (en) Pharmaceutically active composition and dispensing device
WO1999021574A3 (en) Enhancement of morphogen activity
ES2190201T3 (en) MEDICATION FOR THE PROPHYLAXIS AND / OR THE TREATMENT OF THE BREAST CARCINOMA CONTAINING A STEROID INHIBITOR OF THE AROMATASE.